2
195
5
| Cat. No. | Product Name | ||
|---|---|---|---|
| CL0046 | 5-HT Receptor antagonist/agonist kit | ||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| L2300 | 离子通道库 | 946 compounds | |
| A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; | |||
| DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | ||
| DP3000 | 离子通道靶向化合物库 | ||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
| A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
| L3800 | NF-κB 通路分子库 | 560 compounds | |
| A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
| L8400 | 血液病分子库 | 524 compounds | |
| A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
| L3600 | 细胞因子抑制剂库 | 613 compounds | |
| A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
| L8720 | 细胞焦亡化合物库 | 1077 compounds | |
| 1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
| A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
| L5100 | 含氟化合物库 | 583 compounds | |
| A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
| L1500 | GPCR靶点分子库 | 1633 compounds | |
| A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
| L1580 | GPCR库Plus | 338 compounds | |
| Well-chosen 338 GPCR targeting compounds with unique structures; | |||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
| A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
| L1600 | 激酶抑制剂库 | 2230 compounds | |
| A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
| L8500 | HIF-1化合物库 | 1352 compounds | |
| A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； | |||
| L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
| A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
| L6600 | 胃肠炎天然产物库 | 223 compounds | |
| A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
| L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
| Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research. | |||
| L7700 | 神经再生化合物库 | 529 compounds | |
| A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
| A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L5300 | 线粒体靶向库 | 447 compounds | |
| A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L6610 | 抗感染天然产物库 | 1070 compounds | |
| A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L2195 | 抗前列腺癌化合物库 | 2096 compounds | |
| 2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L2910 | 抗氧化化合物库 | 1040 compounds | |
| Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of a... | |||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
| A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
| L4800 | 血管生成库 | 1370 compounds | |
| A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
| L5900 | 血脑屏障通透化合物库 | 516 compounds | |
| A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L9700 | 内质网应激化合物库 | 193 compounds | |
| A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
| L4500 | 抗真菌库 | 253 compounds | |
| A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
| L2521 | 糖酵解化合物库 | 560 compounds | |
| 560 glycolysis-related active compounds for high-throughput and high-content screening. | |||
| L2600 | 神经信号分子库 | 2011 compounds | |
| A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L2140 | 癌细胞分化化合物库 | 413 compounds | |
| A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
| A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening； | |||
| L4200 | FDA 上市药物库 | 1729 compounds | |
| 1729个FDA批准药物的独特集合，可用于高通量筛选和高内涵筛选； | |||
| L6160 | Ro5类药天然产物库 | 2743 compounds | |
| A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
| L9000 | 细胞凋亡化合物库 | 1796 compounds | |
| A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
| L1900 | 抗糖尿病库 | 690 compounds | |
| A unique collection of 690 diabetes related compounds; | |||
| L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
| A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study； | |||
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| L1380 | 转录因子库 | 704 compounds | |
| Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
| L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
| A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | |||
| L2560 | 代谢化合物库 | 2350 compounds | |
| A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
| L1000 | 上市药物库 | 2863 compounds | |
| A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L3200 | 自噬库 | 1248 compounds | |
| A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L9810 | 抗纤维化化合物库 | 1180 compounds | |
| A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
| L1200 | 表观遗传库 | 960 compounds | |
| Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
| A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
| L7200 | 钙通道分子库 | 143 compounds | |
| A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| L1110 | 微管靶向化合物库 | 80 compounds | |
| A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS; | |||
| L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
| 3158个上市及药典分子集合，可用于高通量筛选和高内涵筛选； | |||
| L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 240 compounds | |
| A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
| L8600 | 泛素化化合物库 | 214 compounds | |
| A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening； | |||
| L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
| A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | |||
| L1310 | 细胞骨架化合物库 | 590 compounds | |
| A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS； | |||
| L7900 | 成骨分子库 | 320 compounds | |
| A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
| A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
| L2570 | 人代谢物化合物库 | 4532 compounds | |
| A unique collection of 4532 human metabolites for high-throughput, high-content screening. | |||
| L2000 | 抑制剂库 | 7618 compounds | |
| A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L6140 | 糖类及苷类化合物库 | 364 compounds | |
| A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS； | |||
| L6620 | 抗寄生虫天然产物库 | 233 compounds | |
| A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L1720 | 核苷类化合物库 | 337 compounds | |
| A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
| L6110 | 生物碱类天然产物库 | 468 compounds | |
| A unique collection of 468 natural alkaloids can be used for high throughput and high content screening； | |||
| L6810 | 中药单体化合物库 | 2688 compounds | |
| A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism； | |||
| L6020 | 天然产物单体化合物库 | ||
| L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
| A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
| L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
| The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
| L5510 | 肝脏毒性化合物库 | 1040 compounds | |
| A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | |||
| L2520 | 糖代谢化合物库 | 708 compounds | |
| 708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
| L4600 | 植物来源化合物库 | 3076 compounds | |
| A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
| L9820 | β-内酰胺类化合物库 | 105 compounds | |
| A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | |||
| L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
| The library of highly soluble 3D structural diversity fragments contains 1081 compounds. | |||
| L2900 | 氧化还原化合物库 | 1279 compounds | |
| 1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
| L4660 | 神经疾病库Plus | 1246 compounds | |
| Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
| A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L7100 | 抗肥胖化合物库 | 1359 compounds | |
| A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | |||
| L1510 | 核受体化合物库 | 420 compounds | |
| A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
| 54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
| L4510 | 抗寄生虫库 | 336 compounds | |
| 336 well-chosen unique anti-parasitic small molecules; | |||
| L5200 | 抗代谢疾病化合物库 | 1558 compounds | |
| A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2200 | 酪氨酸激酶分子库 | 746 compounds | |
| A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
| 369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
| L4100 | TGF-β/Smad靶点化合物库 | 180 compounds | |
| A unique collection of 180 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
| L7300 | 钾通道分子库 | 160 compounds | |
| A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | |||
| L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
| The cysteine covalent library contains 72 compounds. | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
| A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS； | |||
| L3700 | JAK-STAT 化合物库 | 256 compounds | |
| A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
| L6030 | 天然产物衍生物虚筛化合物库 | ||
| L4900 | 心血管毒性化合物库 | 127 compounds | |
| A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | |||
| L9860 | 抗抑郁症化合物库 | 1181 compounds | |
| 1181 compounds associated with depression that can be used for high-throughput and high-content screening | |||
| L6000 | 高通量筛选天然产物库 | 4320 compounds | |
| A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen | |||
| L6150 | 天然产物共价化合物库 | 596 compounds | |
| Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
| L2170 | 肿瘤免疫治疗小分子化合物库 | 454 compounds | |
| A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening； | |||
| L5500 | 毒性化合物库 | 277 compounds | |
| A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
| L1400 | MAPK 抑制剂库 | 367 compounds | |
| A unique collection of 367 compounds targeting MAPK signaling for drug discovery in MAPK related diseases; | |||
| L3410 | 临床前化合物库 | 709 compounds | |
| 709种临床前小分子化合物的特有集合，用于高通量、高内涵筛选； | |||
| L4400 | 抗生素库 | 708 compounds | |
| A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
| L4020 | NO PAINS 化合物库 | 9555 compounds | |
| L7400 | 钠通道分子库 | 128 compounds | |
| A unique collection of 128 sodium channel blockers and agonists for high throughput and high content screening; | |||
| L8300 | 染色质修饰分子库 | 256 compounds | |
| A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
| L2190 | 抗肺癌化合物库 | 1735 compounds | |
| A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study； | |||
| L6710 | 中药抗炎分子库 | 1260 compounds | |
| A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study； | |||
| L8800 | 药物片段库 | 1158 compounds | |
| 1158 drug fragments，a must-have tool for FBDD; | |||
| L5800 | 药物代谢杂质库 | 200 compounds | |
| A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
| L5700 | 精选片段库 | 246 compounds | |
| A unique collection of 246 fragment-like small molecules for FBDD; | |||
| L6010 | 天然产物库 | 3720 compounds | |
| A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L6100 | 天然多酚类化合物库 | 640 compounds | |
| A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L4000 | 经典已知活性库 | 12862 compounds | |
| TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | |||
| L9610 | 环肽库 | 58 compounds | |
| 58 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| DC1230 | 特权片段注释化合物库-Beta amyloid A4 protein | ||
| DC1020 | 特权片段注释化合物库-Spiro Library | ||
| DC1080 | 特权片段注释化合物库-GPCR Taste family | ||
| DC1070 | 特权片段注释化合物库-GPCR Family C | ||
| DC1120 | 特权片段注释化合物库-Thrombopoietin receptors | ||
| DQ3000 | Factor XIa化合物库 | ||
| DC1050 | 特权片段注释化合物库-Voltage-gated | ||
| DC1010 | 特权片段注释化合物库-GPCR Family A | ||
| DC1060 | 特权片段注释化合物库-Kinases | ||
| DC1220 | 特权片段注释化合物库-Aminoacyltransferases | ||
| DC1000 | 特权片段注释化合物库 | ||
| DC1110 | 特权片段注释化合物库-Proteases | ||
| DC1210 | 特权片段注释化合物库-Phosphatases | ||
| DC1130 | 特权片段注释化合物库-Phosphodiesterases | ||
| DC1090 | 特权片段注释化合物库-Ligases | ||
| L1800 | 抗感染化合物库 | 2977 compounds | |
| A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
| DC1170 | 特权片段注释化合物库-Oxidoreductases | ||
| DC1150 | 特权片段注释化合物库-GPCR Family B | ||
| DC1100 | 特权片段注释化合物库-GPCR Frizzled family | ||
| DC1030 | 特权片段注释化合物库-Epigenetics | ||
| DC1200 | 特权片段注释化合物库-Isomerases | ||
| DC1040 | 特权片段注释化合物库-Transferases | ||
| DC1140 | 特权片段注释化合物库-Ligand-gated | ||
| DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | ||
| DC1180 | 特权片段注释化合物库-Lyases | ||
| L4010 | 已知活性化合物库 | 20980 compounds | |
| A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
| L8110 | 细胞重编程化合物库 | 1840 compounds | |
| A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
| A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening； | |||
| L2150 | 抗癌药物库 | 2900 compounds | |
| A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L7110 | 抗高血压化合物库 | 719 compounds | |
| 719 hypertension-related small molecules for high-throughput and high-content screening. | |||
| L5600 | Mini骨架库 | 5033 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5033 compounds representing 5033 scaffolds； | |||
| LF1000 | 预制多样性库 | ||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L7000 | 活性脂质化合物库 | 385 compounds | |
| A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
| L8700 | 铁死亡化合物库 | 800 compounds | |
| A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； | |||
| L2120 | 抗癌临床化合物库 | 2359 compounds | |
| A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
| A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
| L6730 | 抗病毒中药单体化合物库 | 270 compounds | |
| A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
| L6500 | 微生物天然产物库 | 254 compounds | |
| 254种微生物来源的生物活性小分子化合物的特有集合，用于高通量、高内涵筛选； | |||
| L8100 | 细胞周期化合物库 | 695 compounds | |
| A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2110 | 抗癌上市药物库 | 1806 compounds | |
| A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
| A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
| L2180 | 抗肿瘤库Plus | 1468 compounds | |
| Well-chosen 1468 anti-tumor compounds with unique structures; | |||
| L7500 | 凝血与抗凝化合物库 | 154 compounds | |
| A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
| A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
| L9200 | 药物功能重定位化合物库 | 4240 compounds | |
| A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L2152 | 靶向治疗药物库 | 121 compounds | |
| 121 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
| L2193 | 抗肝癌化合物库 | 1816 compounds | |
| 1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
| L6210 | 藏药化合物库 | 754 compounds | |
| A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
| L5610 | Golden骨架库 | 10000 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source； | |||
| L9410 | 共价抑制剂库 | 941 compounds | |
| A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | |||
| L4710 | 非甾体类抗炎化合物库 | 530 compounds | |
| 530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
| L3500 | 组蛋白修饰化合物库 | 362 compounds | |
| A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L7870 | 可溶性羧酸片段化合物库 | 1807 compounds | |
| L9300 | 大环化合物库 | 216 compounds | |
| 216种活性已知的大环化合物，用于高通量、高内涵筛选； | |||
| L2160 | 抗癌活性化合物库 | 2439 compounds | |
| A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
| The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
| L2100 | 抗癌化合物库 | 6854 compounds | |
| A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L3400 | 临床期小分子药物库 | 3142 compounds | |
| A unique collection of 3142 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
| L6220 | 蒙药化合物库 | 960 compounds | |
| A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
| L9210 | 儿童药物库 | 1015 compounds | |
| A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
| L8000 | 干细胞分化化合物库 | 1213 compounds | |
| A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
| L8200 | 抗衰老化合物库 | 3324 compounds | |
| A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
| A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents； | |||
| L2194 | 抗结直肠癌化合物库 | 1565 compounds | |
| 1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
| L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
| High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
| L6200 | 瑶药化合物库 | 225 compounds | |
| A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
| L6700 | 抗癌天然产物库 | 1800 compounds | |
| A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L6300 | 药食同源库 | 1088 compounds | |
| A unique collection of 1088 compounds from food as medicine for high throughput and high content screening; | |||
| L6740 | 抗结直肠癌中药单体化合物库 | 386 compounds | |
| A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
| A unique collection of 477 flavonoids can be used for high throughput and high content screening； | |||
| DF4500 | 多样性核心库Part1 | ||
| L2151 | 化疗药物库 | 51 compounds | |
| 51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
| L4520 | 抗菌活性库 | 921 compounds | |
| A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
| L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
| A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L6130 | 萜类天然产物库 | 349 compounds | |
| A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening； | |||
| L9850 | 口服活性化合物库 | 2484 compounds | |
| A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
| CL0122 | ACE inhibitor kit | ||
| L6900 | 稀有天然产物库 | 284 compounds | |
| A unique collection of 284 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Solution (100× <em><em>in</em></em> DMSO) | |
| C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
Solution <em><em>in</em></em> bottle | |
| C0002 |
Phosphatase Inhibitor Cocktail I (100× ddH2O)
磷酸酶抑制剂 Cocktail I |
Solution (100× <em><em>in</em></em> ddH2O) | |
| C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
2 Tube Solution (100×) | |
| C0001 |
Protease Inhibitor Cocktail
蛋白酶抑制剂 Cocktail |
Solution (EDTA-Free,100× <em><em>in</em></em> DMSO) |
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T11029 | hDHODH-IN-5 | Dehydrogenase | Metabolism |
| hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH, IC50 = 0.91 μM). | |||
| T11028 | hDHODH-IN-4 | Dehydrogenase | Metabolism |
| hDHODH-IN-4 is a potent inhibitor of human dihydrogen dehydrogenase (DHODH). For human recombinant DHODH, its pIC50 is 7.8. hDHODH-IN-4 inhibits measles virus replication with a pMIC50 of 8.8. | |||
沪公网安备 31010602006700号
